1. A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer. (November 2019) Authors: Besse, Benjamin; Barlesi, Fabrice; Demedts, Ingel; Fuentes Pradera, Jose; Robinet, Gilles; Gazzah, Anas; Soldatenkova, Victoria; Frimodt-Moller, Bente; Kim, Jong Seok; Vansteenkiste, Johan Journal: Lung cancer Issue: Volume 137(2019) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2019) Authors: Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimod... Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗